2004
DOI: 10.5649/jjphcs.30.1
|View full text |Cite
|
Sign up to set email alerts
|

Limited Sampling Strategy for Estimating Area under the Concentration Curve for Mycophenolic Acid in Renal Transplant Recipients with Co-administration of Tacrolimus.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
10
0

Year Published

2010
2010
2024
2024

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 10 publications
(10 citation statements)
references
References 24 publications
0
10
0
Order By: Relevance
“…3 Although many LSSs for estimation of TAC exposure have been reported for the adult kidney transplant population, all existing LSSs for TAC 4-10 use a steroid-based protocol (as documented 4,6,7,9,10 or assumed 5,8 ) and/or involve other concomitant immunosuppressants besides MMF. 4,5,7,8 Similarly, all LSSs of MMF (for estimating mycophenolic acid [MPA] exposure) use a steroid-based protocol 10,[11][12][13][14][15][16][17][18][19][20][21][22][23][24][25] and in only four of these studies are the patients on TAC and not cyclosporine. 10,11,24,25 To our knowledge, no published LSSs are available for TAC or MMF in adult renal transplant recipients on a steroid-free regimen.…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation
“…3 Although many LSSs for estimation of TAC exposure have been reported for the adult kidney transplant population, all existing LSSs for TAC 4-10 use a steroid-based protocol (as documented 4,6,7,9,10 or assumed 5,8 ) and/or involve other concomitant immunosuppressants besides MMF. 4,5,7,8 Similarly, all LSSs of MMF (for estimating mycophenolic acid [MPA] exposure) use a steroid-based protocol 10,[11][12][13][14][15][16][17][18][19][20][21][22][23][24][25] and in only four of these studies are the patients on TAC and not cyclosporine. 10,11,24,25 To our knowledge, no published LSSs are available for TAC or MMF in adult renal transplant recipients on a steroid-free regimen.…”
Section: Introductionmentioning
confidence: 99%
“…4,5,7,8 Similarly, all LSSs of MMF (for estimating mycophenolic acid [MPA] exposure) use a steroid-based protocol 10,[11][12][13][14][15][16][17][18][19][20][21][22][23][24][25] and in only four of these studies are the patients on TAC and not cyclosporine. 10,11,24,25 To our knowledge, no published LSSs are available for TAC or MMF in adult renal transplant recipients on a steroid-free regimen. It is unclear if these same equations (developed using a steroid-based protocol) could be applied to steroid-free protocols using TAC and MMF.…”
Section: Introductionmentioning
confidence: 99%
“…Regression lines were derived by the Deming regression method. Differences between the measured and estimated values of CCr were analyzed by using the following mean prediction error (ME%) and mean absolute prediction error (MAE%) indices: lefttrueME%=1ni=1npredictedCCrCCrCCr×100,MAE%=1ni=1n||predicted0.5emCCrCCrCCr×100. …”
Section: Methodsmentioning
confidence: 99%
“…Of these, nine articles presented 25 LSSs derived from patients cotreated with cyclosporine [29][30][31][32][33][34][35][36][37] and four articles presented 53 LSSs derived from patients cotreated with tacrolimus. [38][39][40][41] Patients and Data Collection Table 1 shows the baseline demographic and clinical characteristics of study participants. These were comparable to those of our overall transplant population (data not shown).…”
Section: Limited Sampling Strategiesmentioning
confidence: 99%
“…38-41 Pawinski et al 38 collected 50 MPA AUC 0-12 profiles from 21 renal transplant recipients at 1 to 2 weeks and at 3 months posttransplant. No mention was made of the race of participants or cotreatment with corticosteroids.The remaining three studies all involved Japanese kidney transplant recipients [39][40][41]. All were treated with MMF, tacrolimus, and corticosteroids, but across the studies, MPA…”
mentioning
confidence: 99%